Categories: Web and IT News

Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel

Trends and Forecast for the Cell Therapy Technology Market
Trends, opportunities, and forecast for the global cell therapy technology market from 2017 to 2028 by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, and others), process (cell processing, cell preservation, distribution and handling, and process monitoring and quality control), cell type (T-cell, stem cell, and others), end use industry (biopharmaceutical and biotechnology companies, and others), and region

Lucintel’s latest market report analyzed that cell therapy technology provides attractive opportunities in biopharmaceutical and biotechnology companies, CROs & CMOs, and research institutes & cell banks. The cell therapy technology market is expected to reach $8.7 billion by 2028 with a CAGR of 14.5%. In this market, stem cell is the largest segment by cell type, whereas research institutes and cell bank is largest by end use industry.

Download Brochure of this report by clicking on https://www.lucintel.com/cell-therapy-technology-market.aspx

Based on cell type, the cell therapy technology market is segmented into T-cell, stem cell, and others. The stem cell segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to the increasing need for therapies for neurological diseases and growing awareness of stem cell storage.

Browse in-depth TOC on “Cell Therapy Technology Market”

100 – Figures/Tables

150 – Pages

The Cell Therapy Technology Market is marked by the presence of several big and small players. Some of the prominent players offering cell therapy technology include Pharmicell, Corestem, Chiesi Farmaceutici, Tego Science, and Anterogen.

Request Sample Report:

https://www.lucintel.com/cell-therapy-technology-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com  Tel. 972.636.5056

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

The post Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel first appeared on PressRelease.cc.

Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel first appeared on Web and IT News.

awnewsor

Recent Posts

Brunner Acquires AdSkate, Expanding AI-Powered Marketing Intelligence and Creative Performance Capabilities

Leading independent integrated marketing agency Brunner acquires AdSkate to add AI-powered creative analytics and marketing…

3 hours ago

DataTerrain Brings Automation-Led BI Migration to Enterprises Moving from Alteryx to Microsoft Fabric

DataTerrain simplifies Alteryx to Microsoft Fabric migration through automation, delivering faster implementation, reducing costs, and…

3 hours ago

CRM Masters Expands Beyond CRM With Ecommerce and App Development Services

CRM Masters Infotech provides Zoho, Salesforce, and HubSpot implementation services, along with eCommerce, web, and…

3 hours ago

As Enterprises Seek GEO Solutions That Ensure Outcome, GenOptima Presents Its Enterprise Framework

As enterprises increasingly evaluate Generative Engine Optimization (GEO) vendors based on their ability to ensure…

3 hours ago

GenOptima Launches Results-as-a-Service GEO Infrastructure to Help Enterprises Ensure Outcome in AI Search

GenOptima, an enterprise Generative Engine Optimization (GEO) infrastructure provider, announced the launch of its Results-as-a-Service…

3 hours ago

FingerMotion Reports Q1 2027 Financial Results

The post FingerMotion Reports Q1 2027 Financial Results first appeared on PressReleaseCC. FingerMotion Reports Q1…

3 hours ago

This website uses cookies.